Skip to content
OpenCapital
Get started

Dermata Therapeutics, Inc. DRMA Q3 2025 earnings

Reported November 14, 2025 · Before market open

Diluted EPS-$1.65Miss by $0.06
EPS estimate-$1.59

Next report

Aug 18, 2026 (in a month)
EPS estimate-$0.55

Versus estimates

Diluted EPS

Q1 2026-$0.48Beat by $0.05Q4 2025-$1.52Beat by $0.02
Q3 2025-$1.65Miss by $0.06
Q2 2025-$1.66Beat by $1.24Q1 2025-$4.50Miss by $4.05Q4 2024-$3.15Miss by $1.65

Ask the moment Dermata Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Dermata Therapeutics, Inc. report Q3 2025 earnings?
Dermata Therapeutics, Inc. (DRMA) reported Q3 2025 earnings on November 14, 2025 before market open.
What were Dermata Therapeutics, Inc.'s Q3 2025 revenue and EPS?
Dermata Therapeutics, Inc. reported diluted EPS of $-1.65 for Q3 2025.
Did Dermata Therapeutics, Inc. beat estimates in Q3 2025?
EPS missed the consensus estimate of $-1.59 by $0.06.
How did Dermata Therapeutics, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 19.1% from $-2.04.
Where can I find Dermata Therapeutics, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001493152-25-023419) and the 10-Q periodic report (0001493152-25-023474) directly on SEC EDGAR. The filing index links above go to sec.gov.